Diabetes Pens also called insulin pens are used by people with diabetes to inject insulin. The pens include an insulin cartridge, a dial to measure dosage.
This report contains market size and forecasts of Diabetes Pens in global, including the following market information:
- Global Diabetes Pens Market Revenue, 2017-2022, 2023-2028, ($ millions)
- Global Diabetes Pens Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Diabetes Pens companies in 2021 (%)
The global Diabetes Pens market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Reusable Insulin Pens Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Diabetes Pens include Novo Nordisk, Eli Lilly, Sanofi, BD, Ypsomed Holding, Dongbao, Owen Mumford, Ganlee and Delfu. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Diabetes Pens manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Diabetes Pens Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Diabetes Pens Market Segment Percentages, by Type, 2021 (%)
- Reusable Insulin Pens
- Disposable Insulin Pens
Global Diabetes Pens Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Diabetes Pens Market Segment Percentages, by Application, 2021 (%)
- Hospital & Clinic
- Retail Pharmacy
- Online Sales
Global Diabetes Pens Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Diabetes Pens Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Diabetes Pens revenues in global market, 2017-2022 (Estimated), ($ millions)
- Key companies Diabetes Pens revenues share in global market, 2021 (%)
- Key companies Diabetes Pens sales in global market, 2017-2022 (Estimated), (K Units)
- Key companies Diabetes Pens sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Novo Nordisk
- Eli Lilly
- Sanofi
- BD
- Ypsomed Holding
- Dongbao
- Owen Mumford
- Ganlee
- Delfu
